Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × cMET-dysregulated Advanced Solid Tumors × Caffeine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 2 cMET-dysregulated Advanced Solid Tumors 1 Pain 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Gastrointestinal Stromal Tumors 1 Fatigue 1 Diverticulitis 1 Confusion 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Anxiety Disorders 1

Interventions

capmatinib 2 Rosuvastatin Calcium 1 Midazolam 1 Digoxin 1 Caffeine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02520752 2020-12-10

A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors

Novartis

Phase 1 Completed

Other solid neoplasm

cMET-dysregulated Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡